Danaher Corporation (BVMF:DHER34)

Market Cap	816.65B
Revenue (ttm)	137.44B
Net Income (ttm)	21.72B
Shares Out	n/a
EPS (ttm)	29.75
PE Ratio	37.59
Forward PE	25.83
Dividend	0.16 (0.41%)
Ex-Dividend Date	Jun 26, 2025

Volume	507
Average Volume	782
Open	39.34
Previous Close	39.17
Day's Range	38.65 - 39.67
52-Week Range	36.27 - 57.37
Beta	0.80
RSI	60.79
Earnings Date	Jul 22, 2025

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment offers bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manuf...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1969
• Employees: 63,000
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: DHER34

Financial Performance

In 2024, Danaher's revenue was $23.88 billion, a decrease of -0.06% compared to the previous year's $23.89 billion. Earnings were $3.90 billion, a decrease of -17.79%.

Financial numbers in USD